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Significance of the monoclonal rheumatoid factor in the patho-
genesis of glomerulonephritis associated with IgG.IgM(k) essential
mixed cryoglobulinemia. F. Bartolomeo, A. L'Abbate, V. Misef-
an, G. Barbiano di Belgiojoso, A. Tarantino, G. Colasanti, A.
Caccamo, and Q. Maggiore. Centro di Fisiologia Clinica
C.N.R., Reggio Calabria, Divisione di Nefrologia e Dialisi-Os-
pedale Maggiore; 'Ca' Granda"; 'Policlinico;" 'S. Carlo Bor-
romeo," Milano. In essential mixed cryoglobulinemia (EMC) the
cryoprecipitable complex is a IgG and a monoclonal 1gM en-
dowed with rheumatoid activity. This study aims at verifying
whether these patients have glomerular deposits of immunoglob-
ulins developing a rheumatoid activity and whether their pres-
ence correlates to the clinical, immunologic, and histologic se-
verity of glomerulonephritis (GN). The study was conducted on
23 renal biopsy samples of 22 patients with EMC and membrano-
proliferative GN. The evidence of immunoglobulin deposits with
rheumatoid activity was found in 13 of the 23 biopsies examined,
and in all cases it depended on 1gM deposits. The positive pa-
tients showed, compared to negative patients, an involvement of
kidney function significantly more severe and a more active form
of the condition, as evidenced by lower C3 and C4 levels. On the
contrary, no significant differences were found in the severity of
histologic lesions. These observations suggest that the Igu-
IgM(k) cryocomplex is involved in GN pathogenesis, but only as
a worsening factor of the morbid process.
Changes in the glomerular capillary wall and proteinuria atten-
dant to minimal change glomerulopathy, extramembranous gb-
merulonephritis, and pure toxemia of pregnancy. L. Cagnoli, S.
Casanova, S. Pasquali, U. Donini, and P. Zucchelli. Divisione
di Nefro/ogia e Dialisi, Servizio di Microscopia Elettronica, Os-
pedale "M. Malpighi," Bologna, Italy. Recent experimental
data seem to suggest that proteinuria may occur when any one of
the layers making up the glomerular capillary wall is modified. In
the literature, there are very few reports on the relations between
capillary wall lesions and proteinuria in human pathology. We
looked for any correlations between changes in the epithelial lay-
er, basal membrane, and the endothelial layer and proteinuria in
14 patients with minimal change glomerulopathy (MC), 14 with
extramembranous glomerulonephritis (EMG), and 13 with pure
toxemia of pregnancy (TP). In all cases a semiquantitative analy-
sis of elementary lesions by light microscopy and a quantitative
evaluation of the degree of pedicel fusion with an electron micro-
scope were performed. We found that the extent of epithelial
lesions is well correlated to the degree of proteinuria attendant to
MC and EMG, whereas with TP a significant correlation exists
only between endotheliosis and proteinuria. Conclusion. Pro-
teinuria per se does not seem to justify the occurrence of epithe-
hal changes in the presence of human gbomerulopathies, and also
lesions of the inner layer of the capillary wall are likely to modify
its function as a filter of circulating proteins.
Platelet mediators of vascular permeabilization and phbogosis.
G. Camussi, M. C. Deregibus, F. Bussolino, C. Tetta, G. Eman-
uelli, and G. Calcamuggi. Laboraiorio di Immunopatologia del-
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Maggiore S. G. Battista e della Ia C/mica Medica Universitd di
Torino, Italy. The degranulation of human platelets, which con-
tain a complex of substances developing a permeabilizing and
phlogistic activity similar to those present in neutrophils, plays
an important role in the storage of immunocomplexes (IC) at vas-
cular and glonierular level and in tissue damage. We present data
relating to the characterization of vascular permeability factors
secreted by human platelets under an immunologic stimulus, per-
formed in the following way: (/) platelets directly stimulated by
ICs under a different Ag/Ab ratio; (2) platelets stimulated by the
"platelet activating factor" (PAF) as obtained by basophile de-
granulation. Permeabilization appears to be connected to an active
secretion from platelets, both simultaneously with and in ab-
sence of aggregation, of cationic platelets (CP) not dialyzable at a
mol wt ranging from 25,000 to 31,000 daltons. These CPs, puri-
fied during three chromatographic steps (DEAF-Sephadex, and
Sephadex G-100 and G-25), are responsible in vivo for a bipha-
sic permeabilization. The first rapid phase (10 to 15 mm) is hista-
mine-dependent, whereas the slow second histamine-independ-
ent phase (2 to 3 hr) is characterized by a marked leukocytic
infiltration. The in vitro study shows that platelet CPs: (1) are
able to degranulate basophils and mastocytes and to induce the
release of anaphylaxis mediators (histamine, serotonin, PAF);
(2) cause the aggregation of PMNs and generate in serum a chem-
otactic activity on PMNs; and (3) are endowed with a specific
chemotactic activity on mononucleate phagocytes.
Study of changes in the systemic fibrinolytic potential during
dialysis. C. Canavese, P. Stratta, M. Dogliani, M. Paola, A. Pa-
citti, and A. Vercellone. Divisioni di Nefrologia e Dialisi, Os-
pedale Maggiore S. Giovanni Battisia e della Città di Torino.
Cattedra di Nefrologia Medica, Italy. A fibrinolytic activation is
known to exist during extracorporeal circulation, which is im-
puted to a stimulation of Hagemann's factor or to the release of
tissular activators. The relations between fibrinolytic system and
hemodialysis have been studied less. From previous research
studies, we had gathered that there was a steady decrease in lysis
times at the end of dialysis, which at first had been taken as an
index of a simultaneous contact activation of the coagulation and
fibrinolysis cascade. Actually, a deeper insight into the problem
was made possible by the concomitant use of four methods for
studying beginning- and end-dialysis fibrinolysis in 60 patients
under periodical dialysis for a total of 96 applications: (I) lysis of
diluted clot in phosphate buffer; (2) lysis of diluted clot in acetate
buffer; (3) euglobin lysis in acetate buffer; (4) lysis area of eu-
globins on Astrup's plates. The interest of the comparison of
these methods originates from the peculiar sensitivity each one
shows to different components of the fibrinolytic system: activa-
tors, inhibitors, plasminogen. We observed the following: (I)
The speeding up of lysis time is steady (90% of cases) with the
phosphate buffer method, more sensitive to inhibitors. In partic-
ular, the lessening of differences between the various dilutions
clearly shows that the speeding up is secondary to a decrease in
the level of inhibitors. The correction of uremic hypofibrinolysis
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is thus proposed as a parameter of dialytic efficacy. (2) Lysis
with acetate, less sensitive to inhibitors, proves to be accelerated
less frequently at end dialysis (60% of cases). (3) Fibrinolytic
activators increased significantly in 56% of cases only. The lower
increase was observed in patients with the most severe dyslip-
emias and the highest vascular damage.
Effect of propranolol on parathormone and calcitonin secretion
in patients with kidney transplant. S. Casati, C. Galmozzi, D.
Brancaccio, D. Rurale, A. De Vecchi, A. Aroldi, G. Fogazzi,
G. Graziani, and Ponticelli C., Divisione di Nefrologia e Dialisi,
Osped. Policlinico, Mi/ano, Italy. Calcium, phosphate, alkaline
phosphatase, and OH-proline plasma levels, PTH levels (1-84;
1-46; 1-34 fractions), and the hand and clavicle's distal head ra-
diographs were studied in 24 patients with a kidney transplant
functioning normally from 18 to 96 months, divided into two ho-
mogeneous groups as to age, transplantation age and diuretic
therapy, and in 10 normal subjects. The 1st group was treated
with propranolol whereas the 2nd group never had received beta-
blockers. No changes were found either in calcium, phosphate,
alkaline phosphatase plasma levels or in the radiologic incidence
of osteodystrophy between the two groups of transplanted pa-
tients, nor between the latter and normal subjects. PTH levels in
1st group patients were comparable to normal controls but signif-
icantly lower (P < 0.05 and P < 0.Ot) than in 2nd group patients
for all PTH fractions. The two groups of transplanted patients
showed similar (calcitonin) CT levels, both higher than those of
controls (P < 0.0001). Some patients of the 2nd group were
given 80 mg of propranolol orally. Two hours after this acute
dosage, a decrease in PTH values (mean, —20%) concomitant
with a CT increase (mean, + 10%) without changes in calcemia
and phosphoremia could be observed. These data seem to indi-
cate that parathyroid cells, even after a protracted stimulus con-
nected to uremia, are still sensitive to drugs acting on mem-
brane receptors. The clinical usefulness of propranolol therapy
for the inhibition of hyperparathyroidism in transplanted patients,
however, requires a supplement of prospective studies.
Use of Chlorambucil in the frequently relapsing pediatric ne-
phrotic syndrome. M. R. Ciardi, F. Ginevri, F. Perfumo, and R.
Gusmano. Servizio di Nefrologia e Dialisi, Istituto G. Gas/mi,
Genova, Italy. The most debated therapeutic problem of minimal
change nephrotic syndrome (NS) is the treatment of "frequent
relapsers" (32% of cases in pediatry). We report our experience
with Chlorambucil in 34 patients (mean age, 6.2 yr; age range, 2.9
to 12 yr), for whom the diagnosis had been based on clinical
(55%) and histologic criteria. The mean duration of the condition
before the immunosuppressive treatment was 30.9 months. The
average dose of Chlorambucil was 0.23 mg/kg/day and the dura-
tion of treatment 60 days. Results. In 28 patients, no relapses
were found following a mean followup of 24 months (13 to 62
months). The remaining 6 showed, on an average, a relapse 11.1
months after the end of treatment. The frequency of relapses af-
ter steroid therapy alone was 4.3/patient/year. The side effects
observed were definitely less than those found following a ste-
roid therapy: leukopenia in 4 patients (WBCs less than 2,500/
mm3), 2 of which had accompanying thrombocytopenia, after 54
days of treatment on an average, and 1 patient with a fit after 20
days of therapy. The aspects requiring a discussion are: (a) ad-
visability of the immunosuppressive treatment in pediatric mini-
mal changes NS; (b) selection of the immunosuppressant; (c) mo-
ment when the treatment should begin; (d) duration of treatment.
Study of humoral and cellular immunity in minimal change gb-
merubonephritis. R. Coppo, P. Stratta, Ortolani, F. Giacchino,
G. Camussi, 0. Sernia, D. Riva, R. Boero, A. Vercellone, and
G. Piccoli. Divisioni Nefrologia e Dialisi Ospedale S. Giovanni,
Torino; Clinica Medica IV, Università di Milano; Divisione di
Pediatria, Ospedale M. Vittoria, Torino, Italy. The recent sug-
gestion of a pathogenesis from circulating immunocomplexes for
minimal change glomerulonephritis (GN) (Stuhlinger, Levinsky)
has reawakened the interest in this nephropathy, which shows
several puzzling aspects. We examined 15 cases of minimal
change GN, performing biopsy examinations and evaluating all
of them under light and immunofluorescence microscopy; 7 of
them were examined also under electron microscopy. Eight cas-
es of UN in children with selective and corticosensitive protein-
uria were also examined. Eleven cases were studied during a 4-to
li-month followup characterized by acute phases and remission.
The patients were evaluated with three tests indicative of serum
immunocompiexes (solid phase Clq with ELISA enzyme-label-
ing; immunofluorescence on polymorphonucleates; precipitation
in polyethylene glycol with qualitative analysis). Total and spe-
cific IgE; IgG, IgA, and 1gM; C3, C4, and C3PA; C3d (C3 degra-
dation product); basophils; and E and EAC rosettes were also
evaluated. Healthy subjects and 15 membranous UN or focal gb-
merulosclerosis were examined as control group. The results ob-
tained in minimal change GN contrast with what others report
regarding the positivity of the tests for immunocomplexes. The
latter were not found to stray significantly from normal values
when examined with the above methods. Cell immunity tests
supplied data showing a good correlation with clinical phases.
The number of basophils was not altered significantly, whereas
high levels both of total IgE and specific IgE were found in a
fairly high percentage of cases for the most common allergens.
IgA mesangial-deposit glomerubonephritis and arterial hyper-
tension. E. Degli Esposti, C. Chiarini, A. Gattiani, T. Montanan,
A. Santoro, J. Solis, A. Sturani, A. Zuccald, and P. Zucchelli.
Divisione di Nefrologia Ospedale M. Malpighi, Bologna, Italy.
We investigated the behavior of the renin-angiotensin-aldoste-
rone system (RAAS), of plasma catecholamines (PC), and of ex-
changeable sodium pool (NaE) in 32 patients, hypertensive and
normotensive, affected by IgA glomerulonephritis (UN). GFR
was 80 mllmin in all cases. PRA, both in clinostatism and ortho-
statism, was significantly higher in normotensive than it was in
hypertensive patients. Such PRA values are also significantly
higher than those found in a control population. Plasma aldoste-
rone was not significantly different in clinostatism in the two pa-
tient groups, but it was significantly higher in orthostatism in the
normotensive patients. The aldosterone clinostatic/orthostatic
ratio showed in patients with IgA UN a sharply steeper slope
than that found in the control population, which is the index of an
exaggerated reactivity of aldosterone to the orthostatic stimulus.
On an average, NaE was higher in hypertensive than in normo-
tensive patients. No statistically significant difference exists be-
tween the two groups as regards heart rate, PC levels, and mean
duration of nephropathy. We infer a RAAS stimulation in normo-
tensive patients with IgA GN, which though an aldosterone-de-
pendent effect, could lead to a progressive increase in NaE at-
tended by arterial hypertension.
Nephritic factor and anticomplementary activity in patients with
primary and secondary glomerubonephritides. A. De Vecchi, P. L.
Bencini, G. Montagnino, P. Scalia, A. Constantino, and A. Ta-
rantino. Divisione di Nefrologia e Dialisi, Ospedale Policlinico,
Milano, Italy. Two hundred seventy samples of serum from pa-
tients with glomerulonephritis, either primary or secondary to
lupus erithematosus (LES), or mixed cryoglobulinemias (MC)
were examined for factors able to activate the complement. The
serum was mixed with an equal quantity of normal serum or
MgEGTA plasma incubated at 37° C for 60 mm. The native C3
percentage was determined either by immunofixation or bidi-
mensional immunoelectrophoresis before and after incubation.
Sera producing a native C3 consumption higher than 35%, the
upper limit of the range observed when testing sera of 13 normal
subjects, were considered as positive. The addition of EGTA and
Mg, which prevents the classic pathway from being activated,
enabled us to discriminate between an aspecific anticomplemen-
tary activity (ACa) and an activation through the alternative
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pathway (NeF). An ACa was present in 19% of samples tested,
with an incidence of 79% in dense-deposit glomerulonephri-
tides (DD), 36% of acute glomerulonephritides (Ac), 33% of
hernolytic uremic syndromes (HUS), 11% of LES, and 4% of
subendothelial deposits membranoproliferative glomenilo-
nephritides (SE). It was absent in MCs. NeF was positive in 90%
of sera of patients with DD, 33% of HUS, in one LES case and
one SE. In DDs the positivity was present and it even caused the
consumption of native B factor after incubation. Thus, NeF ap-
pears to be a characteristic finding of DDs, where an activation
of the alternative pathway is confirmed by frequently present
Factor B activation products and by the complement's com-
ponents. Only the chromatographic characterization will define
the identity between NeF present in DDs and NeF to be found in
other nephropathies, or whether just one or both are IgGs as
stated by others.
IgA nephropathy: Is it a single entity? A. Lupo, C. Paro/ini, G.
Previato, C. Loschiavo, E. Valvo, T. Faraggiana, N. Tessitore,
and G. Maschio. Div isione di Nefrologia di Verona; 1st Istituto
di Anatomia Pato/ogica deli' Universita di Roma, Italy. Thirty-
five patients with predominant IgA deposits diffused in the me-
sangium (not associated to systemic diseases) were divided into
two groups based on the site of deposits with immunofluorescent
(IMF) techniques: solely mesangial deposits (group 1: 15 pts.),
deposits in the mesangium and in some points of basal mem-
branes (group 2: 20 pts.). Light microscopy: Group 1 = mesan-
gial GN (11); focal GN (5); unclassified (3); accompanied by
tubulointerstitial lesions (9). IMF: Group 1 = deposits almost
entirely consisting of IgA and C3. Group 2 = IgG (12), 1gM (8),
and Fib (6) associated to the prevailing IgA-C3 picture. Electron
microscopy: Large mesangial deposits in group 1; 5 pts. in group
2. Subepithelial deposits: no pts. in group 1; 6 pts. in group 2.
Basal membrane lesions (swollen lamina rara interna; trans-
lucent areas in the lamina rara externa): 2 pts. in group 1; 16 pts.
in group 2. Differences were found between the two groups as
regards the onset mode: relapsing macroscopic hematuria in 80%
of group 1 and 30% of group 2; accompanying proteinuria: 20%
in group 1, 70% in group 2; renal failure: 6% in group t, 25% in
group 2. Conclusions. The finding of IgA deposits prevailing in
the mesangium does not imply a single anatomoclinical entity,
but at least two populations of patients in which both clinical and
laboratory data and possibilities of basal membrane lesions
(more frequent in group 2) differ. Pathogenesis and prognosis
may be different for the two groups.
PTH heterogeneity and methodologic problems in renal failure:
Results of RIA determination with three immune sera samples
identifying various loci of the hormone's molecule. R. Majorca, G.
Cancarini, L. Cristinelli, M. Cecchettin, S. Be/loll, and A. Alber-
tini. Div isione Nefro/ogica e Laboratorio di Ormono/ogid degli
Spedali Clviii di Brescia, Italy. The heterogeneity of para-
thormone (PTH) in peripheral blood and the different half-lives
of its fragments represent a major difficulty for the evaluation of
the actual levels of active hormone and of the influence of VFH
on some tubular functions, especially in kidney failure. Immuno-
reactive PTH (iPTH) plasma levels were determined in 50 sub-
jects showing a kidney function ranging from normal to 1/3d be-
low normal values (creatininemia, 0.5 to 13 mgldl) with three dif-
ferent immune sera: (1) COOH-TF, identifying the terminal
COOH fragment with long half-life, and the integral hormone
(PTH 1-84); (2) COOH-MF, identifying the COOH-terminal site
of fragments containing the hormone's initial sequence, NH2-ter-
minal; and (3) NH2-TF, identifying the NH2-terminal fragment
and the 1-84 hormone. iPTH values found with each one of the
three immune sera correlated inversely with the glomerular fil-
trate: the values found with normal GFR were 14 times higher for
the COOH-TF and 3.3 times higher for the COOH-MF in respect
to NH2-TF, while with a GFR of 5 mllmin the values were re-
spectively 5 and 2.7 times higher for COOH-TF and COOH-MF
in respect to NH2-TF. With decreasing GFR, the mean percen-
tual increments of COOH-MF and NH2-TF were significantly
higher than those of COOH-TF. There was a highly significant
exponential correlation between the values obtained with each
one of the immune sera and the phosphate Tm (COOH-TF r =
—0.479; COOH-MF r = —0.560; NH2-TF r =
—0.630) and the
renal output of nephrogenous cAMP (COOH-TF r = 0.467;
COOH-MF r = 0.614; NH2-TF r 0.573). Such a relationship,
however, could be indirect, attendant to the existing relationship
on the one side between the retention of PTH fragments, even
inactive, and GFR, and between GFR and PTH, thus between
GFR and NcAMP production and PO4Tm decrease on the other
side. The exponential relation between the iPTH values deter-
mined with three immune sera and the GFR reproduces the phe-
nomenon of retention due to a reduced filtration accompanying
the use of polypeptides and microproteins of various nature. It
can be reasonably assumed that at low GFR levels, the iPTH
concentrations partly are the manifestation of retention and
buildup of PTH or its active fragments, as well as the outcome of
a hyperactivity of parathyroids.
Study of nephrogenous cyclic guanosine monophosphate as a
mediator of P'FH activity on renal tubules: Study on normal sub-
jects and on nephropathic subjects showing a various reduction of
glomerular filtrate. R. Majorca, G. Cancarini, L. Cristinelli, E.
Movi/li, M. Cecchettin, G. Pizzocolo, and A. Albertini. Divisione
Nefrologica e Laboratorio di Ormonologia degli Spedali Civili
di Brescia, Italy. A synthesis in kidney cortical tubular cells of
cyclic guanosine monophosphate (cGMP), stimulated by PTH
and potentiated by calcium, and an increase in urinary excretion
of cGMP following the administration of PTH or an increase in
endogenous PTH have been reported in the literature. The in-
crease in cGMP production has been connected with a role of
this nucleotide, together with cAMP (both as second messen-
gers), on the tubular transfer of calcium and phosphorus. The
real significance of this metabolic route in human physiology and
pathology, however, is unknown. The urinary excretion of
'nephrogenous" cGMP (NcGMP) and the contemporary excre-
tion of "nephrogenous" cyclic adenosine monophosphate
(NcAMP) were studied in a group of normal and nephropathic
subjects showing a different reduction of glomerular filtrate (GF)
(plasma creatinine, 0.5 to 13 mg/dl) and a different level of iPTH.
Both at normal GF values and at pathologic GF and iPTH values,
levels of NcGMP correlated with GF, iP'FH values, and NcAMP.
Both nucleotides correlated inversely with P04 fractional reab-
sorption and directly with the maximal tubular reabsorption of
phosphates (Tm P04/dl GF). Said data speak in favor of a real
significance of renal tubular cGMP mediation (beside that of
NcAMP) in PTH regulation of phosphate tubular reabsorption.
Effects of captopril (SQ14225), an oral inhibitor of the con-
version enzyme, on some humoral parameters in hypertensive pa-
tients, both in clinostatic and passive orthostatic position. A. Mor-
ganti, J. Lopez-Ovejero, T. Pickering, andJ. H. Laragh. Istituto
di Ricerche Cardiovascolari, Milano e Cardiovascular Hyper-
tension Center, Cornell University, New York, USA. To evaluate
the effects of the chronic inhibition of the conversion enzyme on
the sympathetic nervous system, on renin, and on other aldoste-
rone secretion regulating factors, we determined the mean arteri-
al pressure (MAP), heart rate (HR), noradrenaline (NA), adrena-
line (A), plasma renin activity (PRA), plasma aldosterone (PAIdO),
cortisole (Pa) and potassium (PK) before and after a 7-day treat-
ment with captopril in 15 sodium-replete hypertensive both in
clinostatic position and during 30 mm of passive orthostatism
(65° tilt). In the clinostatic position, captopril induced a signifi-
cant decrease in MAP (19 3 mm Hg) and in PAId. (4.8 1.9 ng/
dl) accompanied by an increase in PRA (12.3 3.2 ng/mllhr) and
in PK (0.26 mEq/liter). No changes were found in HR, NA, A and
P. MAP remained unchanged both before and during treatment
during tilt. Nevertheless, while orthostatism-induced HR and A
increases in the two conditions were similar, NA increases were
significantly higher after treatment (476 61 vs. 306 34 mg/mI,
P < 0.05). Before and following captopril, tilt-induced PRA and
PAId0 increases were parallel and correlated, while those in P
and Pk were just marginal. The conclusion is that captopril
lowers the arterial pressure without inducing, in clinostatism, a
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contemporaneous increase in the sympathetic activity. Thus, the
concomitant increase in PRA depends on the interruption of the
negative feedback of angiotensin II on renin release. The per-
sistant response of PAIdO to the tilt following captopril and its ratio
to PRA response suggest that during orthostatism the enzyme
block is partially overcome. When a reduced generation of angio-
tensin H is present, the necessary sympathetic response to main-
tain MAP unchanged during tilt is higher than under control con-
ditions.
Prostacyclin and renin release in man. C. Patrono, G. Ciabat-
toni, G. A. Cinotti, F. Pugliese, A. Maseri, and S. Chierchia.
Istituto di Farmacologia Universitâ Cattolica, ha Clinica Medi-
ca Università di Roma, Laboratorio di Fisiologia Clinica del
C.N.R. Università di Pisa, Italy. Recently Oates et al showed
that prostacyclin (PGI2) stimulates in animals the release of renin
both in vitro and in vivo. This study aimed at highlighting a simi-
lar role in man. PG!2 sodium salt was infused i.v. in 5 healthy
male volunteers ranging in age from 27 to 50 years at 2.5, 5, 10,
and 20 ng/kglmin doses. During PGI2 infusion, plasma renin ac-
tivity (PRA) increased in a dose-dependent way from 0.86 0.5
ng/ml/hr (mean SD) under basal conditions to 2.14 0.8 ng/ml/
hr (P < 0.005). Mean arterial pressure decreased in 3 subjects
and remained unchanged in 2 without a statistically significant
correlation to PRA increase. The radioimmunoassay (RIA) of 6-
keto-PGF1, and PGF in urine did not show any change in their
ratio, which suggested a renal origin of 6-keto-PGF1,,, a stable
derivative of PG!2. Based on this assumption, we determined the
urinary excretion of 6-keto-PGF1 in 6 healthy women following
the infusion of furosemide (F) (50 mg, i.v.). The excretion of 6-
keto-PGF1,, rose from a basal value of 55 20 pg/mm up to 175
22 pg/mm (mean SD) during the first 15 mm following F. At the
same time PRA rose from 0.77 0.4 to 3.7 1.0 ng/ml/hr. The
daily urinary excretion of 6-keto-PGF1,, was measured also under
basal conditions and following indomethacin (150 mg/day) in an
adult woman (25 yr) suffering from Bartter's syndrome. Basal
values of 6-keto-PGF1,, were 262 57 ng/24 hr vs. a mean of 50
25 ng/hr in 19 healthy women; PRA basal values were 13.6 ng/ml/
hr. Indomethacin caused at the same time a 60% inhibition of 6-
keto-PGF1 excretion and a 54% reduction of PRA. In con-
clusion, PG!2 appears to be the compound of the kidney prosta-
glandin system more likely to mediate its role in controlling renin
release in man.
Study of the hypothafamus-hypophyseal axis in the prepubertal
uremic child. F. Perfumo, M. Giusli, P. Trucchi, C. Mangini, R.
Mortara, and R. Gusmano. Servizio di Nefrologia e Dialisi, Isti-
tuto G. Gaslini, Istituto di Endocrinologia deli' Universith, Gen-
ova, Italy. The hypophyseal secreation of thyroid-stimulating
hormone (TSH), PRL, and growth hormone (GH) was studied in
13 patients under chronic dialysis (D) for 4 to 36 months, 6 pa-
tients with chronic renal failure (CRF) under conservative treat-
ment (Ccr, = 22.7 9.6), and in 7 normal children (C) of the
same age. All subjects showed a puberal growth P1 according to
Tanner. TRH (100 sg) were administered i.v. at 9.00 A.M., and
blood samples were drawn at —30, 0, + 10, 20, 30, 45, 60, 90, and
120 mm. In children under dialysis, the test was performed on













D(l3) 3.4 15.1 45.3 63.1 3.5 10.2
age: = 7.3 0.7 2.9 10.7 17.5 0.8 2.2
!RC (6) 2.7 9.7 6.0 26.7 4.5 8.2
age: = 7.4 0.7 1.5 1.5 5.8 2.4 2.9
C (7) 2.8 14.8 5.5 33.0 2.9 5.0
age: = 8.8 0.3 2.2 2.0 7.5 1.1 1.3
These data show that even in stage-P1 uremic children changes in
the hypothalamus-hypophyseal axis are present: (a) delayed and
protracted TSH response, (b) increase in PRL basal rate (D vs.
CRF, D vs. C, P < 0.01) and its decreased response to the stimu-
lus (base vs. max in D, NS; base vs. max in C and CRF, P <
0.01); (c) presence of a paradoxical GH response (base vs. max
in D, P < 0.01; in C and CRF, NS).
Cell-mediated immunity and dialytic treatment: Therapeutic
possibilities with bovine thymic factor. G. P. Segoioni, G. Trioio,
P. A. Tovo, F. Giacchino, P. Stratta, P. F. Martini, A. Vercel-
lone. Cattedra di Nefrologia Medico, II C/mica Pediatrica Univ.
di Torino, Italy. The involvement of cell-mediated immunity dur-
ing chronic hemodialysis (RDT) is a constant characteristic of
the state of these patients and suggests a series of pathogenetic
and therapeutic questions. With a view to gain insight into this
deficiency aspect, we treated a group of 7 patients under RDT,
negative to DNCB skin test, over 7 to 30 days with bovine thym-
ic factor (TP1) by controlling both the behavior of the passive
simple (Ep) and thymosin-stimulated (Ep + T) rosettes at the
beginning and at the end of cycle, and the in vivo DNCB behav-
ior. Methods. Observation pool: 7 patients; mean age, 57 years
(46 to 76 yr); mean dialysis, age 59 months (24 to 144 months) at a
thrice weekly rate, excluded from the transplantation pro-
gramme. DNCB test: sensitizing dose of 2 mg; challenging dose,
100 and 500 g; positive with reddening and induration area> 10
mm 0 after 48 hr. Joudal's Ep test (nv. 63 10), Wara's Ep + T
test (incubation at a 25 mg Tp1/l06 cell concentration). Horo-
witz's active rosettes test. Tp1 treatment: 50 mg/day for 7 days
s.c.; 50 mg s.c. twice a week for 30 days. Results. Time 0: 3
patients, reduced Ep; 3 normal Ep; 1 increased Ep. Four pts, 3 of
which normal with Ep + T that could be stimulated at time 0.
This characteristic seems to be peculiar only to the uremic popu-
lation. Time 7: 6/7, normal Ep, I border line, 4/7 normal, which
still could be stimulated with Ep + T. Time 30: 7/7 normal; 0/7
could be stimulated with Ep + T; 1/7 DNCB+; 6/7 DNCB—.
Conclusions. Based on results, TP1 appears to play a restorative
and normalizing role as regards T responses surveyed with Ep in
uremic patients. On the contrary, a response dichotomy exists
between Ep (normalized) and DNCB, always negative. Such a
behavior reminds us of some nonuremic situations (lympho-
pathies), for which such a dichotomy was correlated to the pres-
ence of plasma inhibitors (apoferritine).
Study of tissular fibrinolysis in primary and secondary glomeru-
lonephritides. P. Stratta, C. Canavese, G. Mangiarotti, G. Ema-
nuelli, G. P. Segoloni, and A. Vercellone. Divisioni di Nefro-
logia e Dialisi dell'Ospedale Maggiore S. Giovanni Battista e
della Città di Torino, Cattedra di Nefrologia Medica 1st
dell'Università di Torino, Italy. The fibrinolytic activity, a basic
component of the circulatory balance within a glomerular capil-
lary, contributes to the phagocytic capacity of the mesangium as
well as to the elimination of local microthrombotic processes. In
experimental GN, a change in glomerular fibrinolysis has been
documented, and the use of fibrinolytic agents brought about an
increase in local lysis, sometimes with positive effects on the be-
havior of nephropathy. Conversely, the use of antifibrinolytic
agents brought about opposite results. With the technique of fi-
brin microslides on 4-pt bioptic slices, we studied the tissular fi-
brinolysis in 108 patients with primary and secondary GN di-
vided as follows: 4 with minimal change GNs, 5 with focal gb-
merulosclerosis, 8 with membranous GN, 16 with
membranoproliferative GN, 6 with intracapillary proliferative
GN, 6 with extracapillary proliferative GN, 13 with mesangial
proliferative GN with C3 deposits, 25 with mesangial prolifera-
tive with !gA-!gG deposits, and 24 with secondary forms. To
evaluate the results, we compared the Kwann-Astrup's "focal
lysis time" temporal system with Todd-Pandolfi's semi-
quantitative technique, according to which three behavior
groups can be identified: (I) absent or hardly represented lysis
area; (2) wide and confluent lysis areas; (3) complete lysis ring
around the tissue slice. Minimal change GN and focal glomeru-
losclerosis show a reduced fibrinolytic activity (group 1) com-
pared to normal controls, whereas lupus GN, cryogbobulinemia
GN, and ShOnlein-Henoch GN fall in group 3, as also at focal
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lysis time they show a very early fibrinolytic capacity (15 mm).
Glomerulonephritides with IgA-IgG mesangial deposits distrib-
ute among groups I and 3, with two different subtypes: as rule to
a higher tissular fibrinolysis corresponds a histopathologic aspect
of a more evident vascular involvement. The other types of GN
showing a not univocal behavior are more difficult to define.
Most of them fall in group 2, which results are difficult to corre-
late. Also the direct correlation between mesangial proliferation
extent and lysis area is worth mentioning, which confirms the
close relations existing between phagocyte activity and glomeru-
lar fibrinolytic activity. The study of tissular fibrinolysis allows
us to obtain useful elements for the evaluation of histopatholog-
ic, immunohistochemical, and laboratory data concomitantly
with the involvement of coagulation as an intermediate damaging
mechanism of primary and secondary GN.
Zinc urinary excretion in patients with relapsing calcium neph-
rolithiasis. M. Surian, G. Graziani, G. Colussi, A. Antonacci, A.
Aroldi, Pd. Giachetti, F. Masi, U. Civati, and L. Minetri. Divi-
sioni di Nefrologia e Biochimica delI'E.O. Niguarda e
deIl'Ospedale Maggiore Policlinico di Milano, Italy. Zinc inhib-
its the precipitation of calcium oxalate and calcium phosphate.
The efficacy of thiazidic compounds in relapsing calcium neph-
rolithiasis (RCN) could also be partly due to an increase in zinc
urinary excretion (ZnE). Plasma Zn, fasting ZnE, and following
oral administration of I g of calcium (Pak's test) were evaluated
in 33 patients with RCN (26 with idiopathic hypercalciuria, of
which 14 were renal (R) and 9 were intestinal (I); 3 primary hy-
perparathyroidism and 4 normocalciuria) and in 17 normal sub-
jects (N). Zn plasma levels in N (85 16 1sg/dl), R (92 15), 1(87
6), and in patients with RCN taken as a group (T) (86.6 12.7)
were not statistically different. Under basal conditions, Zn in N
(0.29 0.21 g!dl GFR) does not differ significantly from R (0.41
0.14), 1(0.36 0.22) and T (0.39 0.16). The calcium load
does not cause significant ZnE changes over basal values neither
in N or R, Land T. But after load, ZnE differs in R(0.45 0.24), 1
(0.39 0.2), and T (0.4 0.22) from N (0.23 0.11), P < 0.005,
< 0.05, and < 0.001, respectively. The ZnEICaE ratio, under
basal conditions, is significantly lower in T (3.43 1.98, P <
0.02) and in R (2.74 0.95, P < 0.005) than in N (7.45 6.2), not
in I. This behavior reflects the different basal calciuria in the
groups examined. ZnE/CaE after load and ZnE/MgE, basal and
after load, are not different in the various groups. In conclusion,
patients with RCN show normal Zn plasma and urinary values.
Three-year experience in the prevention of relapsing calcic neph-
rolithiasis. N. Tessitore, A. D'Angelo, F. Pagano, C. Loschiavo,
A. Fabris, A. Lupo, A. Tasca, P. Morachiello, E. Valvo, G. Pre-
viato, and U. Maschio. Divisione Nefrologia Instituti Os-
pitalieri, Verona, ía C/mica Medica e C/mica Urologica, Univer-
sità di Pat/ova, Italy. During the past 3 years, 230 patients with
relapsing calcic nephrolithiasis (RCN) was studied. Hyper-
calciuria, either absolute (> 350 mg/day) or relative (> 200 mg/
day under a low-calcium diet) and hyperuricuria (> 750 mg/day)
were present in 60% and 34% of cases, respectively. For the pa-
tients with hypercalciuria, a primitive hyperparathyroidism (con-
firmed by surgery) in 8%, intestinal calcium hyperabsorption in
46%, reduced renal calcium absorption in 42%, and phospaturic
tubulopathy in 4% of cases were diagnosed. Two hundred seven
patients were treated with thiazidic (25 to 50 mg/day) and amilo-
ride (2.5 to 5 mg/day). Allopurinol (200 mg/day) was also admin-
istered to 75 of them. During 1,518 years of pretreatment obser-
vation, 922 calculi were expelled (4.4 calculi/patient, 0.6 calculi!
yr). During 349 years of posttreatment observation, 15 calculi
were expelled (0.07 calculi/patient, 0.04 calculi/yr). Differences
are statistically significant. The drug was discontinued out of in-
tolerance in 15 patients (7%). Serial controls during treatment
showed a significant decrease in calciuria, no changes in cal-
cemia and phosphoremia, a slight decrease i kaliemia, and a
moderate increase in uricemia (in patients not treated with allo-
punnol). Thiazidic agents, alone or associated with allopurinol,
proved effective in preventing RCN relapses and changed radi-
cally the prognosis of this syndrome.
Hypertension in dialysis: Usefulness of studying the thyroid
function for the interpretation of the relations between autonomic
nervous system and arterial pressure. A. Zuccalâ, C. Chiarini, E.
Degli Esposti, A. Ligabue, N. Monetti, A. Santoro, A. Sturani,
and P. Zucchel/i. Divisione di Nefrologia Ospedale M. Malpighi,
Bologna, Italy. The recent literature described an increase in
plasma values of catecholamines (CP) in hypothyroid patients. In
our previous reports we had assumed that the presence of a sub-
clinical hypothyroidism, as found in some normotensive uremic
patients, would cause an increase in CP. This secondary increase
could mask the possible correlations between CP levels and AP.
During this study, the following parameters were evaluated in 34
uremic patients under RDT: T3, T4, Revers T3, thyroid-stimulat-
ing hormone (TSH), free T3 (FT3), and T4 fractions (FT4), CPs,
autonomic function test (diving reflex, Valsalva's maneuver, tilt
test). Our data show that a statistically significant reverse rela-
tion does not exist between thyroid hormone and CP levels for
normal or lower borderline thyroid function values. Only when
clear-cut hypothyroidism pictures are present are high CP levels
found also in uremic patients. Disregarding these cases of clear
hypothyroidism, a good correlation is obtained between CP lev-
els and mean AP (r = 0.55; P < 0.01), which confirms the impor-
tance of sympathetic hyperactivity in the genesis of hypertension
in dialysis.
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Plasma renin and dopamine-/3-hydroxylase activities and plasma
aldosterone concentration in toxemic pregnancy. G. Annat, D.
Raudrant, M. Vincent, J. Thou/on, C. A. Bizollon, and J. Sas-
sard. Département de Physiologie, Facultés de Médecine et de
Pharmacie, Service d'Obstétrique de l'Hôpital de Ia Croix-
Rousse, Université Lyon I, Lyon, France. Toxemic and normo-
tensive pregnant women were compared for plasma renin activi-
ty (PRA), aldosterone (PAIdO), and dopammne-/3-hydroxylase
(DBH). At term, hypertensive patients exhibited higher levels of
PRA and PAldo, but similar levels of DBH, progesterone, and es-
tradiol. Their elevated blood pressure was significantly cone-
lated to their levels of PRA. During delivery, levels of PRA in-
creased significantly in toxemic patients in spontaneous labor.
Venous and arterial cord PRA levels were higher in babies born
to hypertensive mothers than in babies born to normoterisive
mothers. Three days postpartum, maternal PRA levels were
